Monday 5/22/17- Nutraceutical International
Corporation (NUTR) $28.00 and HGGC, LLC , a leading middle-market private
equity firm, today announced that they have entered into a definitive
agreement under which Nutraceutical will be acquired by an affiliate of HGGC
in a transaction valued at approximately $446 million, including debt to be
refinanced. Under the terms of the agreement, Nutraceutical stockholders
will receive $41.80 in cash (without interest) for each outstanding share of
Nutraceutical common stock they own, which represents a 49% premium to the
Company's closing stock price on May 19, 2017, the last full trading day
before today's announcement, and a 15.6% premium to the Company's all-time
high closing stock price.
What They Do:
Nutraceutical is an integrated manufacturer, marketer, distributor and
retailer of branded nutritional supplements and other natural products sold
primarily to and through domestic health and natural food stores.
A negative heart safety signal picked up in a
clinical trial of Amgen's osteoporosis drug Evenity means the
product will not be approved and on the U.S. market this year, as previously
expected, the company said Sunday.
Amgen's osteoporosis setback will likely be seen
as a providing a commercial boost to Radius Health RDUS $34.92 , which
secured U.S. approval in April for a competing osteoporosis drug, Tymlos.
What They Do:
Radius is a science-driven fully integrated biopharmaceutical company that is
committed to developing and commercializing innovative therapeutics in the
areas of osteoporosis, oncology and endocrine diseases.
Nutanix (NTNX) $16.00, a leader in
enterprise cloud computing, today announced the private cloud deployment of
SAIC Volkswagen, a Sino-German joint venture between Shanghai Automotive
Industry Corporation (SAIC Motor) and Volkswagen Group. The speed and ease of
deployment enabled the automotive giant to continue innovating efficiently
without worrying about the fundamental IT support needed across its many
departments ranging from research and development (R&D) to manufacturing,
transportation, logistics, car sales and consumer relations programs.
What They Do:
Nutanix makes infrastructure invisible, elevating IT to focus on the
applications and services that power their business.
Features available at SmallCapReview.com include in-depth profiles of select
Small-Cap/Penny Stocks as well as the most comprehensive and up to date news
available on the small-cap market.
No investor should assume that reliance on the views, opinions or
recommendations contained herein will produce profitable results. Nothing
within our site should be construed as an offer or solicitation to buy or sell
products or securities. The companies we profile may lack an active trading
market for their securities, investing in such securities is highly
speculative and carries a high degree of risk.
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on
small-caps, penny stocks and microcaps. SmallCapReview has built a loyal
opt-in following for their investor products by providing a newsletter at no
cost, sent to subscribers, highlighting select stocks in play.